This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Companies From Several Industries to Report Q4 Earnings
by Zacks Equity Research
Companies From Several Industries to Report Q4 Earnings
Looking Forward to an Eventful Week; Plus L, CNA, DO
by Mark Vickery
With investors' attention being drawn toward the end of this trading week ??? including another possible U.S. government shutdown at the end of this week, hopes of U.S./China trade negotiations making some progress before the March 1 deadline, statements from Federal Reserve members and a Brexit vote on Thursday ??? we still have Q4 earnings reports to digest through this, the last of the earnings-heavy weeks.
MOH or JYNT: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
MOH vs. JYNT: Which Stock Is the Better Value Option?
Are Investors Undervaluing Molina (MOH) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Tap Potential Earnings Beat With 5 Top Stocks
by Sanghamitra Saha
These top-ranked stocks are likely to beat on bottom line in their next releases.
DXC Technology (DXC) Q3 Earnings & Revenues Top Estimates
by Zacks Equity Research
DXC Technology's (DXC) fiscal Q3 results reflect strength in digital business. However, declining legacy application services business poses a headwind.
Is a Beat in Store for Molina Healthcare (MOH) Q4 Earnings?
by Zacks Equity Research
Molina Healthcare (MOH) is expected to gain in Q4 on the back of membership strength and its streamlining initiative. However, the same might be partly offset by a dismal Marketplace business.
Why Molina Healthcare (MOH) Stock Might be a Great Pick
by Zacks Equity Research
Molina Healthcare (MOH) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
WellCare Health (WCG) Q4 Earnings Beat Estimates, Soar Y/Y
by Zacks Equity Research
WellCare Health's (WCG) Q4 earnings gain from Meridian buyout and growth in membership.
Humana's (HUM) Q4 Earnings Surpass Estimates, Improve Y/Y
by Zacks Equity Research
Humana's (HUM) fourth-quarter earnings gain on the back of Medicare Advantage membership growth and operating efficiencies.
When Does a Trade Deal Happen? Zacks February Market Strategy
by John Blank
Trade war tariff damage. Caution tied to policy uncertainty. Those are the biggest factors holding back stock prices globally. On the U.S. China trade war, here are my three scenarios and their probabilities.
Molina (MOH) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Molina (MOH) closed at $138.57 in the latest trading session, marking a +1.62% move from the prior day.
Centene's (CNC) Earnings Top Estimates in Q4, Surge Y/Y
by Zacks Equity Research
Centene's (CNC) Q4 earnings ride high on robust revenues, solid acquisitions and stronger Health Insurance Marketplace business.
Zacks.com featured highlights include: Molina, Dana, DICK???S, Centene and Covenant
by Zacks Equity Research
Zacks.com featured highlights include: Molina, Dana, DICK???S, Centene and Covenant
What's in Store for Humana (HUM) Stock in Q4 Earnings?
by Zacks Equity Research
Higher enrollment and strong segmental results are expected to help Humana (HUM) in fourth-quarter earnings.
5 Stocks That Brokers Currently Love: Do You?
by Zacks Equity Research
Given their thorough understanding of the stock market, investors should pay heed to broker advice in order to design a winning portfolio.
The Zacks Analyst Blog Highlights: Office Depot, Rent-A-Center, SkyWest, Molina and Shoe Carnival
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Office Depot, Rent-A-Center, SkyWest, Molina and Shoe Carnival
What Lies Ahead for Centene (CNC) Stock in Q4 Earnings?
by Zacks Equity Research
Centene's (CNC) fourth-quarter earnings are likely to gain traction from growth in revenues and membership strength, partly offset by high operating costs.
5 Top Stocks to Own This February
by Tirthankar Chakraborty
U.S. equities rally to best month in three years as upbeat corporate earnings, encouraging developments on the political front and the Fed's dovish stance uplift investor sentiment.
4 Healthcare Stocks Likely to Beat Estimates in Q4
by Zacks Equity Research
An aging population, prevalence of chronic health conditions and greater utilization of healthcare services should drive the industry's growth, partly offset by an increase in expenses.
Top Ranked Value Stocks to Buy for January 31st
by Zacks Equity Research
Here are four stocks with buy rank and strong value characteristics for investors to consider today, January 31st
Anthem's (ANTM) Q4 Earnings Beat Estimates, Improve Y/Y
by Zacks Equity Research
Anthem's (ANTM) Q4 earnings surge on the back of operating performance and strong growth across all core businesses.
HCA Healthcare's (HCA) Q4 Earnings Top Estimates, Surge Y/Y
by Zacks Equity Research
HCA Healthcare's (HCA) fourth-quarter earnings rise on the back of robust same facility admissions.
Get Explosive Returns with the Filtered Zacks Rank 5 Strategy
by Benjamin Rains
Today we are going to show investors how to add two relatively simple filters to our Zacks Rank #1 criteria that narrows down the number of stocks and often increases its performance as well.
What's in the Cards for Anthem (ANTM) This Earnings Season?
by Zacks Equity Research
Anthem (ANTM) is likely to gain from Q4 results on revenue and membership growth, partly offset by higher expenses.